Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, April 25, 2024 · 706,387,773 Articles · 3+ Million Readers

Global $1.24 Bn Sterility Indicators Markets to 2025 - Increasing R & D Activities, Number Of Drug Launches, & Focus On Quality And Sterility

Dublin, April 25, 2019 (GLOBE NEWSWIRE) -- The "Sterility Indicators Market Size, Share & Trends Analysis Report By Type (Chemical, Biological), By Technique (Heat, Low Temperature, Filtration, Radiation, Liquid), By End User, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global sterility indicators market size is expected to reach USD 1.24 billion by 2025

It is anticipated to expand at a CAGR of 10.9% over the forecast period. Strict regulations regarding healthcare products and high emphasis on sterility parameters and measures for the prevention of Hospital Acquired Infections (HAIs) are projected to drive the market growth.

Increasing number of geriatric population prone to chronic conditions is primarily driving the demand for drugs and medical devices globally.Governments in developing economies like India and China are focusing on providing cost-effective, high quality medications. The Union Cabinet of India has provided USD 13.16 billion to the National Health Mission (NHM) from April 2017 to March 2020.

Currently, India has the highest U.S. Food and Drug Administration (FDA)-approved manufacturing facilities outside U.S. It also accounts for 22.0% of the overall approved U.S. FDA plants. Thus, demand for sterility testing services and products is anticipated to rise over the forecast period.

Standardized manufacturing protocols, introduction of novel products, and adoption of new technologies has led to harmonization of quality and sterility testing standards in the healthcare industry. This has created a need for not only aseptic manufacturing techniques but also for efficient and reliable sterilization monitoring processes.

Furthermore, organizations such as the Agency for Healthcare Research and Quality and Centers for Medicare and Medicaid Services are also raising awareness about the need for stringent regulations for safety and quality testing services of healthcare products. Such steps are anticipated to bode well for expansion of the sterility indicators market over the forecast period.

Further key findings from the study suggest:

  • Biological indicator segment captured the largest market share in 2017. Extensive usage as compared to chemical indicators owing to their reliability is anticipated to propel the segment growth
  • North America is expected to maintain its dominance with the largest market share over the forecast period owing to the presence of a large number of major companies and a high adoption of advanced technologies
  • Asia Pacific is expected to exhibit a lucrative CAGR during the forecast period. Presence of a large untapped market and availability of supportive government regulations are expected to attract global players
  • Some of the major players in the sterility indicators market include Getinge AB; Cantel Medical Corporation; 3M Company; Cardinal Health Inc.; Matachana Group; Mesa Laboratories; and Anderson Products Inc.

Key Topics Covered:

Chapter 1 Methodology And Scope

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends & Scope

Chapter 4 Market Definitions

Chapter 5 Industry Outlook
5.1 Market Variable Analysis
5.1.1 Supportive Government Investment In The Healthcare Industry
5.1.2 Increasing R & D Activities
5.1.3 Increasing Number Of Drug Launches
5.1.4 Increasing Focus On Quality And Sterility
5.1.5 Rising Burden Of Hospital Acquired Infections
5.1.6 Increasing Application Of Sterilization In Pharmaceutical And Biotechnology Industry
5.2 Market Restraint Analysis
5.2.1 Influx Of Low Quality Products From Local Manufacturers

Chapter 6 Business Environment Analysis
6.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
6.2 Porter's Five Forces Analysis

Chapter 7 Type Business Analysis
7.1 Sterility Indicators Market: Type Movement Analysis
7.1.1 Chemical Indicators
7.1.1.1 Chemical Indicators Estimates And Forecast, 2014 - 2025
7.1.1.2 Class 1 Indicators
7.1.1.3 Class 2 Indicators
7.1.1.4 Class 3 Indicators
7.1.1.5 Class 4 Indicators
7.1.1.6 Class 5 Indicators
7.1.1.6.1 Class 5 Indicators Market Estimates And Forecast, 2014 - 2025
7.1.1.6.2 Tapes
7.1.1.6.3 Strips
7.1.1.6.4 Others
7.1.2 Biological Indicators
7.1.2.1 Biological Indicators Market Estimates And Forecast, 2014 - 2025
7.1.2.2 Spore Ampoules
7.1.2.3 Spore Suspensions
7.1.2.4 Self - Contained Vials
7.1.2.5 Spore Strips

Chapter 8 Technique Business Analysis
8.1 Sterility Indicators Market: Technique Movement Analysis
8.1.1 Heat Sterilisation
8.1.2 Low Temperature Sterilisation
8.1.3 Filtration Sterilisation
8.1.4 Radiation Sterilization
8.1.5 Liquid Sterilisation

Chapter 9 End User Business Analysis
9.1 Sterility Indicators Market: End - User Movement Analysis
9.1.1 Hospitals
9.1.1.1 Hospitals Market Estimates And Forecast, 2014 - 2025
9.1.1.2 Pharmaceutical Companies
9.1.1.3 Medical Device Companies
9.1.1.4 Clinical Laboratories/Research Centers
9.1.1.5 Others

Chapter 10 Regional Business Analysis
10.1 Sterility Indicators Market: Regional Movement Analysis
10.1.1 North America.
10.1.1.1 North America Market Estimates And Forecast, 2014 - 2025
10.1.1.2 U.S.
10.1.1.3 Canada
10.1.2 Europe
10.1.2.1 Europe Market Estimates And Forecast, 2014 - 2025
10.1.2.2 Germany
10.1.2.3 U.K.
10.1.2.4 Italy
10.1.2.5 France
10.1.2.6 Denmark
10.1.2.7 Greece
10.1.2.8 Spain
10.1.3 Asia - Pacific
10.1.3.1 Asia - Pacific Market Estimates And Forecast, 2014 - 2025
10.1.3.2 Japan
10.1.3.3 China
10.1.3.4 India
10.1.4 Latin America
10.1.4.1 Latin America Market Estimates And Forecast, 2014 - 2025
10.1.4.2 Brazil
10.1.4.3 Mexico
10.1.4.4 Argentina
10.1.5 Middle East And Africa
10.1.5.1 Middle - East And Africa Market Estimates And Forecast, 2014 - 2025
10.1.5.2 UAE
10.1.5.3 Saudi Arabia
10.1.5.4 South Africa

Chapter 11 Company Profiles

  • Getinge Ab
  • Cantel Medical Corporation
  • 3m Company
  • Cardinal Health
  • Matachana Group
  • Mesa Laboratories
  • Anderson Products , Inc.

For more information about this report visit https://www.researchandmarkets.com/r/uvs2yq

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: In Vitro Diagnostics
                    

22157.jpg

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release